Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.

Shanghai Haohai Biological Technology Co., Ltd.*

ɪऎ؀ऎ͛ي߅Ҧٰ΅Ϟࠢʮ̡

(a joint stock company incorporated in the People's Republic of China with limited liability)

(Stock code: 6826)

CONTINUING CONNECTED TRANSACTIONS

SPRAY PUMP CUSTOMIZATION AGREEMENT

Reference is made to the announcement of the Company dated 26 March 2018 regarding, among other things, the entering into the Existing Spray Pump Customization Agreement between the Company and Haohai Changxing and its annual caps. The Existing Spray Pump Customization Agreement expired on 31 December 2020.

The Board announces that on 26 March 2021 (after trading hours) the Company entered into the Spray Pump Customization Agreement with Haohai Changxing, pursuant to which the Company agreed to engage Haohai Changxing to process spray pumps for use in the Company's product packaging until 31 December 2023, setting out the annual caps for each of the three years ending 31 December 2023.

As at the date of this announcement, Haohai Changxing is held indirectly as to 49% by Mr. Jiang Wei, a controlling shareholder of the Company and the spouse of Ms. You Jie, also a controlling shareholder of the Company and a non-executive Director. Ms. You Jie separately indirectly controls 51% in Haohai Changxing. Haohai Changxing is therefore a connected person of the Company under the Listing Rules and the transactions contemplated under the Spray Pump Customization Agreement constitute continuing connected transactions of the Company under Chapter 14A of the Listing Rules.

As the applicable percentage ratios stipulated under Rule 14.07 of the Listing Rules in respect of the transactions contemplated under the Spray Pump Customization Agreement are more than 0.1% but less than 5%, the transactions contemplated under the Spray Pump Customization Agreement are subject to reporting, announcement and annual review requirements but are exempt from the independent Shareholders' approval requirement under Chapter 14A of the Listing Rules.

INTRODUCTION

Reference is made to the announcement of the Company dated 26 March 2018 regarding, among other things, the entering into the Existing Spray Pump Customization Agreement between the Company and Haohai Changxing and its annual caps.

Due to the expiry of the Existing Spray Pump Customization Agreement on 31 December 2020, the Company entered into the Spray Pump Customization Agreement with Haohai Changxing on 26 March 2021 (after trading hours), pursuant to which the Company agreed to engage Haohai Changxing to process spray pumps for use in the Company's product packaging until 31 December 2023, setting out the annual caps for each of the three years ending 31 December 2023.

SPRAY PUMP CUSTOMIZATION AGREEMENT

Date

  • : 26 March 2021 (after trading hours)

    Parties

  • : The Company, as purchaser; and Haohai Changxing, as supplier

    Transaction

  • : Engagement to process spray pumps

    Term

  • : From 1 January 2021 to 31 December 2023

    Annual cap

  • : RMB7,600,000 (equivalent to approximately HK$9,120,000), RMB9,500,000 (equivalent to approximately HK$11,400,000) and RMB11,400,000 (equivalent to approximately HK$13,680,000) respectively for each of the three years ending 31 December 2023

    Pricing basis

  • : The product customization price will be determined on an arm's length basis in the ordinary course of business and on normal commercial terms with reference to the Company's demand for the customized spray pumps and the prevailing market prices and will be reviewed by both parties on a regular basis. The agreed prices shall be no less favourable to the Company than the then prevailing prices of comparable products available in the market. For the purpose of ascertaining the market prices, the Company will make reference to the latest prices charged by independent third parties for products of comparable quality, quantity and specifications.

    Payment terms

  • : The order price can be settled either by one-off payments or by installments. Unless separately agreed between the Company and Haohai Changxing in the purchase order, the Company will make an upfront payment of 50% of the order price based on the quantity of each purchase order and settle the remaining amount within a period of time upon completing the inspection and receiving the invoice issued by Haohai Changxing.

The historical transaction amounts under the Existing Spray Pump Customization Agreement for the three years ended 31 December 2020 were approximately RMB3,584,920 (equivalent to approximately HK$4,301,904), RMB4,588,237 (equivalent to approximately HK$5,505,884) and RMB2,185,511 (equivalent to approximately HK$2,622,613). Under the influences of the novel coronavirus pneumonia epidemic (the "Pandemic"), the demand of the spray pumps of the Company fell due to decreased production of relevant product of the Company in 2020.

The proposed annual caps for the three years ending 31 December 2023 were determined based on arm's length negotiations between the Company and Haohai Changxing, having considered, amongst others, the following factors and assumptions:

(i) the historical procurement volume of the Company, actual market conditions and unexpected market events such as the Pandemic being declared in 2020;

  • (ii) the expected growth of sales volume of relevant products of the Company which make use of the customized spray pumps; and

  • (iii) the prevailing price in the market.

The Spray Pump Customization Agreement is a framework agreement in nature, both parties may sign purchase orders separately according to their needs and subject to the terms under the Spray Pump Customization Agreement to agree on the quantity, specifications, unit price, delivery deadline and method of payment for each order.

REASONS FOR AND BENEFITS OF ENTERING INTO THE SPRAY PUMP CUSTOMIZATION AGREEMENT

By entering into the Spray Pump Customization Agreement, the Group is able to secure a stable supply of spray pumps. The Directors (including independent non-executive Directors) consider that the Spray Pump Customization Agreement is entered into during the ordinary and usual course of business of the Group after arm's length negotiations, and that the terms of such agreement are on normal commercial terms or no less favourable to the Company than the terms offered to independent third parties, and are fair and reasonable and in the interest of the Company and its shareholders as a whole.

INFORMATION ON THE GROUP AND HAOHAI CHANGXING

The Group is principally engaged in the manufacture and sale of biologicals, medical hyaluronate and ophthalmology products, research and development of biological engineering, pharmaceutical and ophthalmology products and the provision of related services.

Haohai Changxing is a company principally engaged in, among other things, the production and sales of plastic products, research and development of biological and plant products, and development of healthcare food products.

IMPLICATIONS OF THE LISTING RULES

As at the date of this announcement, Haohai Changxing is held indirectly as to 49% by Mr. Jiang Wei, a controlling shareholder of the Company and the spouse of Ms. You Jie, also a controlling shareholder of the Company and a non-executive Director. Ms. You Jie separately indirectly controls 51% in Haohai Changxing. Haohai Changxing is therefore a connected person of the Company under the Listing Rules and the transactions contemplated under the Spray Pump Customization Agreement constitute continuing connected transactions of the Company under Chapter 14A of the Listing Rules.

Ms. You Jie, a non-executive Director, has material interest in the Spray Pump Customization Agreement and the transactions contemplated thereunder and has abstained from voting on the resolutions approving the Spray Pump Customization Agreement and the transactions contemplated thereunder at the relevant Board meeting. Mr. Huang Ming, a non-executive Director, also serves as a director of Haohai Changxing and is a related Director for the transactions contemplated under the Spray Pump Customization Agreement according to the listing rules of The Sci-Tech Innovation Board of the Shanghai Stock Exchange, therefore Mr. Huang Ming has also abstained from voting on the resolutions approving the Spray Pump Customization Agreement and the transactions contemplated thereunder at the relevant Board meeting. Save as mentioned above, none of the other Directors has a material interest in the Spray Pump Customization Agreement or the transactions contemplated thereunder or was otherwise required to abstain from voting on this resolution at the relevant Board meeting.

The Board considers that the applicable percentage ratios (as defined under the Listing Rules) of the transactions between the Company and Haohai Changxing during the period from 1 January 2021 to the date of this announcement are less than 0.1%, and accordingly such transactions are fully exempt from reporting, announcement and independent shareholders' approval requirements pursuant to Chapter 14A of the Listing Rules.

As the applicable percentage ratios stipulated under Rule 14.07 of the Listing Rules in respect of the transactions contemplated under the Spray Pump Customization Agreement are more than 0.1% but less than 5%, the transactions contemplated under the Spray Pump Customization Agreement are subject to the reporting, announcement and annual review requirements but are exempt from the independent Shareholders' approval requirement under Chapter 14A of the Listing Rules.

DEFINITIONS

In this announcement, save as the context otherwise requires, the defined terms shall have the following meanings:

"Board"

the board of Directors of the Company

"Company"

Shanghai Haohai Biological Technology Co., Ltd.*€ɪऎ؀ऎ͛ي ߅Ҧٰ΅Ϟࠢʮ̡, a joint stock company incorporated in the PRC with limited liability, and its H Shares and A shares are listed on the Main Board of the Hong Kong Stock Exchange (Stock Code: 6826) and the Sci-Tech Innovation Board of the Shanghai Stock Exchange

(Stock Code: 688366), respectively

"connected person(s)"

has the meaning ascribed to it under the Listing Rules

"controlling shareholder"

has the meaning ascribed to it under the Listing Rules

"Director"

a director of the Company

"Existing Spray Pump

the spray pump customization agreement dated 26 March 2018

Customization

between the Company and Haohai Changxing in relation to the

Agreement"

engagement to process spray pumps which has been expired on 31

December 2020. For further details, please refer to the announcement

of the Company dated 26 March 2018

"Group"

the Company and its subsidiaries

"Haohai Changxing"

Haohai Technology (Changxing) Company Limited*€؀ऎ߅Ҧ€ڗ

ጳϞࠢʮ̡, a company incorporated in the PRC with limited

liability

"Hong Kong

The Stock Exchange of Hong Kong Limited

Stock Exchange"

"HK$"

Hong Kong dollars, the lawful currency of Hong Kong

"Listing Rules"

the Rules Governing the Listing of Securities on the Hong Kong

Stock Exchange

"PRC"

the People's Republic of China

"RMB"

Renminbi, the lawful currency of the PRC

"Spray Pump

the spray pump customization agreement dated 26 March 2021

Customization

entered into between the Company and Haohai Changxing, pursuant

Agreement"

to which the Company agreed to engage Haohai Changxing to

process spray pumps for use in the Company's product packaging

until 31 December 2023

"%"

per cent.

By order of the Board

Shanghai Haohai Biological Technology Co., Ltd.*

Hou Yongtai

Chairman

Shanghai, the PRC, 26 March 2021

As at the date of this announcement, the executive Directors are Dr. Hou Yongtai, Mr. Wu Jianying, Ms. Chen Yiyi and Mr. Tang Minjie; the non-executive Directors are Ms. You Jie and Mr. Huang Ming; and the independent non-executive Directors are Ms. Li Yingqi, Mr. Jiang Zhihong, Mr. Su Zhi, Mr. Yang Yushe and Mr. Zhao Lei.

* **For identification purpose only

Unless otherwise specified, the exchange rate of RMB1.00 = HK$1.20 is adopted in this announcement for illustration purpose only

Attachments

  • Original document
  • Permalink

Disclaimer

Shanghai Haohai Biological Technology Co. Ltd. published this content on 26 March 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 26 March 2021 15:06:05 UTC.